Bellerophon Biotec

Provision of pharmaceuticals, biologicals, and laboratory equipment in the healthcare sector.

About Bellerophon Biotec

Bellerophon Biotec is a Healthcare company. Provision of pharmaceuticals, biologicals, and laboratory equipment in the healthcare sector. Its Indian entity Bellerophon Biotec Private Limited reported revenue of β‚Ή2.9 Lakh. Bellerophon Biotec offers products and services including Pharmaceuticals and Diagnostic Kits. Its focus areas include Medical Equipment, Laboratory Supplies, Diagnostic and Surgical Products and Biotechnology.

Company details

Bellerophon Biotec is recognized as a subsidiary of Chimera Gentec Pvt. Ltd., having been incorporated in 2012 to supply products in the healthcare industry. Quality pharmaceuticals, biologicals, production equipment, modular clean rooms, laboratory furniture, and diagnostic kits are offered by the company in the global market. A strong emphasis is placed on building long-term customer relationships through trusted quality products, with operations based in India. Customer commitment is demonstrated through foundational business practices, ensuring industry needs are met effectively.

Key Metrics
  • Indian entity revenue
    ₹2.9 Lakh

    FY 2020 · +261% YoY

  • Indian entity net loss
    -₹18,494

    FY 2020 · -6% margin

  • Indian entity EBITDA
    -₹19,663

    FY 2020 · -7% margin

Products & Services of Bellerophon Biotec

Bellerophon Biotec offers a comprehensive portfolio of products and services, including Pharmaceuticals and Diagnostic Kits.

Pharmaceuticals
Healthcare Products

Pharmaceuticals and biologicals are manufactured and supplied for medical applications

Diagnostic Kits
Medical Devices

Diagnostic kits and surgicals are produced and distributed for healthcare purposes

Board of directors of Bellerophon Biotec Private Limited (Bellerophon Biotec)

Bellerophon Biotec Private Limited is the primary company behind Bellerophon Biotec. The board of Bellerophon Biotec Private Limited currently have 2 directors; the longest-serving is Pcheena Chawla, appointed in 2012. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Pcheena Chawla
DIN 05348418
Director11 Sep 201214 yrs 1 moBellerophon Biotec Private Limited
Aman Chawla
DIN 05348402
Director05 May 201412 yrs 5 moBellerophon Biotec Private Limited

Financials of Bellerophon Biotec

Figures of Bellerophon Biotec Private Limited, the primary company behind Bellerophon Biotec, for FY 2020. Revenue was ₹2.9 Lakh (+261% year on year). Net loss was -₹18,494 (-6% margin). EBITDA was -₹19,663 (-7% margin). Revenue has grown at a compounded annual rate of +39% over three years and +4% over five years.

  • ₹2.9 LakhRevenue · FY 2020 · +261% YoY
  • -₹18,494Net loss · -6% margin
  • -₹19,663EBITDA · -7% margin
  • ₹1 LakhPaid-up capital
  • +39%Revenue CAGR, 3 years
  • +4%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Bellerophon Biotec Private Limited are on its company page.

Premium access

Detailed financial statements for Bellerophon Biotec

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Bellerophon Biotec

The primary company behind Bellerophon Biotec, Bellerophon Biotec Private Limited, reported revenue of β‚Ή2.9 Lakh for FY 2020, up 261% year on year.

Bellerophon Biotec is recognized as a subsidiary of Chimera Gentec Pvt. Ltd., having been incorporated in 2012 to supply products in the healthcare industry. Quality pharmaceuticals, biologicals, production equipment, modular clean rooms, laboratory furniture, and diagnostic kits are offered by the company in the global market. A strong emphasis is placed on building long-term customer relationships through trusted quality products, with operations based in India. Customer commitment is demonstrated through foundational business practices, ensuring industry needs are met effectively.

Bellerophon Biotec offers Pharmaceuticals and Diagnostic Kits.

Bellerophon Biotec operates through Bellerophon Biotec Private Limited.

The legal entities of Bellerophon Biotec currently have 2 directors, including Pcheena Chawla, Aman Chawla.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available